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Abstract
The organ shortage has become a prominent problem for public health as thousands of
patients die per year because of the limited availability. Research has found that
xenotransplantation could be the solution to this deathly public health issue. By using animal
organs to transplant into humans, there would be a significant increase in availability thus saving
countless lives of those in need of organs. In this article research has been done to show the
barriers of xenotransplantation that cause organ failure and solutions that have been successful in
overcoming those barriers. Barriers that cause organ rejection include immune rejection,
inflammation, coagulative dysfunction, and cross species transmission of retroviruses. Solutions
include various techniques such as CRISPR/Cas9 for gene editing. Additionally, there was
research showing the extensive use xenotransplantation could have in the medical world by
effectively being able to treat a wide variety of diseases such as heart failure, kidney failure, liver
failure, diabetes, burns, and more. The most significant and recent research was in 2022 when
the first pig heart to human xenotransplantation took place. He was able to survive for two
months using a genetically altered pig heart. Research has progressed immensely and has shown
promising success. This suggests that xenotransplantation has the potential to make a difference
in the medical world by providing a limitless amount of animal organs to transplant to patients
with diseases that require a new organ.
Introduction
The world of science is ever-changing and exciting as new discoveries and solutions to
problems are constantly being discovered every single day. Science is the foundational
background for human life as it affects every aspect. Biological research aims to improve life as
much as possible. Organ shortage for transplantation patients has become a major public health
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issue that is progressively getting worse at an alarming rate (Langin et al. 2018). For patients
with severe organ failures, transplantation is proven to be the most effective treatment (Langin et
al. 2018). The overall limited availability of organs has caused countless deaths. On average,
seventeen people die per day waiting for a transplant (Organ…2022). The need for organs will
keep increasing as every nine minutes someone is added to the transplant list (Organ…2022).
Obviously, the number of people waiting for organs drastically outweighs the number of organs
available for transplant (Langin et al. 2018). Patients in need of organs often end up with a
feeling of hopelessness given these statistics. The good thing about the science world is that there
is always hope. Could xenotransplantation be the answer to this deathly problem?
Xenotransplantation is the transplantation of cells, tissues, and organs between members of
different species. There has been continued success in research with xenotransplantation that
shows how it could significantly increase organ availability. The research has progressed from
xenotransplantation between animals of different species to xenotransplantation of animal to
human just this year. Studies have also shown the broad range of diseases that could be treated
with xenotransplantation. The one setback of xenotransplantation is organ rejection. The
increased research has improved knowledge on the reasons why organ rejection takes place.
Barriers include immune rejection, inflammation, coagulative dysfunction, and cross-species
transmission of retroviruses (Niu et al. 2021). Research has seen success in methods to overcome
these barriers which include CRISPR/Cas9, homology recombination, zinc-finger nuclease, and
TALEN (Niu et al. 2021). Being able to perfect xenotransplantation can open a window of new
opportunities for treatment of these life-threatening diseases. Also, there are many ethical
concerns regarding xenotransplantation. Is this considered animal mistreatment? Is it morally
correct? Xenotransplantation clashes with religious beliefs and even human dignity and bodily
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integrity. Despite the known problems, I think that the benefits vastly outweigh the negatives.
With increased extensive research, xenotransplantation is a potential life-saving treatment that
could be the cure to thousands of people in need of organs. Xenotransplantation could be a
potential way to reduce organ shortage by using animals’ organs in humans; furthermore, with
increased extensive research and high regulation, xenotransplantation could save countless lives
by increasing organ availability and transplantation rates.
Background on Xenotransplantation
Aforementioned, xenotransplantation is the process of transplantation between members
of different species. Research has shown potential uses of treatment in multiple animals, but
domestic pigs have proved to be the ideal organ source for humans. Domestic pigs are the best
option because of their similarities to humans in their anatomy, physiology, and organ size (Niu
et al. 2021). Also, pigs have a high reproductive rate due to their fast reproductive maturity and
large litter size (Niu et al. 2021). Being able to breed high amounts of pigs can potentially lead to
an unlimited availability of porcine organs. Economically, domestic pigs have a low maintenance
cost (Niu et al. 2021). Research has still shown there are problems in organ rejection that have
yet to be solved.
Barriers to Xenotransplantation
The one thing holding back xenotransplantation is organ rejection. Organ rejection is
hard enough to overcome between members of the same species, let alone members of different
species. There are many factors that go into organ rejection. The first major challenge is immune
rejection (Niu et al. 2021). The human immune system is an efficient defense mechanism which
usually is extremely advantageous in staying healthy. The immune system can actually be
disadvantageous when it is involved in transplantation. Even in allotransplantation, the immune
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system sees the new organ as an “alien component” and responds by attacking it (Niu et al.
2021). Hyperacute rejection, acute rejection, and chronic rejection are the main types of immune
rejection. Hyperacute rejection is the most severe as it occurs as soon as within minutes after
transplantation (Niu et al. 2021). It leads to necrosis because of decline of organ, thrombosis, and
edema. Acute rejection happens within weeks to months and results in dysfunction of the new
organ (Niu et al. 2021). Chronic rejection takes the longest to occur and results in transplanted
organ dysfunction and possible organ failure (Niu et al. 2021). These conditions are all caused by
the incredibly effective defense mechanism in the human body. These immune rejections can
occur in both allotransplantation and xenotransplantation, but the immune barriers are just harder
to overcome in xenotransplantation. In xenotransplantation, there are more “alien components”,
so a stronger attack by the immune system will be launched. Molecularly, there are differences in
natural antibodies, complement, NK cells, and macrophages (Niu et al. 2021).
Another barrier to xenotransplantation is inflammation. Throughout studies, systemic
inflammation has consistently occurred (Niu et al. 2021). Research has found the molecules
responsible for the inflammation. The main inflammatory markers include C-reactive protein,
histones, cytokines, and chemokines (Niu et al. 2021). Inflammation goes hand in hand with
coagulative dysfunction. Inflammation influences platelet activation and aggregation which often
causes coagulative dysfunction (Niu et al. 2021). Inflammation can even promote the immune
system response. Coagulation involves a combination of platelets, coagulation factors,
endothelial cells (Niu et al. 2021). Due to the negative effect on blood flow, coagulation is a
major cause of organ failure. Along with platelet aggregation and coagulation, thrombosis can
also be triggered. Thrombosis is also a form of coagulation and clotting of blood in a part of the
circulatory system.
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Lastly, there is a risk of cross-species transmission with xenotransplantation.
Transmitting zoonotic pathogenic microorganisms would be a detrimental avoid zoonosis at all
costs. An example of a concerning zoonotic pathogenic microorganism is porcine endogenous
retroviruses, known as PERVs (Niu et al. 2021). The DNA of PERVs is in the pig genome which
is why it can be easily passed down (Niu et al. 2021). So far, there has been little to no data
reported on transmission of PERVs, but it is important to be cautious of this risk. PERVs is just
one microorganism, there are many other that have similar risks. (Niu et al. 2021).
There was also a histological and transcriptome analysis organ rejection when a porcine
heart was transplanted to a monkey (Park et al. 2021). The goal of this study was to highlight
significant factors that played a role in organ rejection. In the monkey blood analysis, there was
an increased count of neutrophils, increased levels of the C-Reactive Protein, and increased
levels of fibrinogen after transplantation indicating a systemic inflammatory response (Park et al.
2021). The histological analysis indicated myocardial infarction and intestinal fibrosis (Park et
al. 2021). In the transcriptome analysis, 2,443 genes were upregulated, and 1,305 genes were
downregulated (Park et al. 2022). In biological pathways, there was an up-regulation in the
ECM-receptor interaction pathway and a down-regulation in the calcium signal pathway (Park et
al. 2021). The ECM-receptor interaction pathway plays a key role in cell survival, shape, growth,
differentiation, migration, and motility. The calcium signal pathway down-regulation can cause
disruption in homeostasis causing heart failure (Park et al. 2021). These regulations similarly
occur in allograft rejection, cardiovascular disease, and heart failure. These were the significant
changes that occurred with organ rejection in xenotransplantation. Using these findings can help
to design gene editing tools to control the pathways.
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Methods to Prevent Organ Rejection
Being able to recognize and understand the problems associated with xenotransplantation
is key in developing the best methods to fix them. To overcome these barriers, treatments such as
gene editing, pharmacological therapy, immunosuppressants, and early weening have shown
great success and potential solutions to preventing organ rejection. CRISPR/Cas9 has been used
most frequently in recent studies. CRISPR/Cas9 is known to be the arguably the least expensive,
most accurate, and most efficient gene editing technique. Xenotransplantation is just one-way
CRISPR/Cas9 can help improve human health. It works by cutting at a certain DNA sequence
which could lead to a potential change in cellular function (Niu et al. 2021). The guide mRNA is
able to find the specific target gene, and then Cas9 breaks the DNA. This break allows for gene
editing to occur. Compared to the other tools, CRISPR/Cas9 has advantages of simplicity and
efficient gene targeting (Niu et al. 2021).
Homology recombination is when a vector exchanges genetic material between the two
homologous sequences, one being endogenous and the other being exogenous (Niu et al. 2021).
This will result in a knockout or knock-in at the target. Although sometimes effective, this
technique has low recombination efficiency in somatic cells (Niu et al. 2021). Because of the
downfalls, this technique is not preferred. Zinc-finger nuclease (ZFN) consists of a complicated
process that involves two key components that are a DNA-binding domain and a DNA-cleavage
domain (Niu et al. 2021). The disadvantage of this gene editing tool is that it is a complicated
process that involves much work and preparation along with relatively low efficiency (Niu et al.
2021). Transcription activator-like effector nuclease, known as TALEN, performs cleavage of
DNA with the Fok I nuclease using the transcription activator-like effector that binds to the DNA
(Niu et al. 2021). Although comparatively better than the ZFN, it is still difficult to clone the
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proteins needed for the technique to be successful. Compared to the other tools, CRISPR/Cas9 is
considered the most effective gene editing tool because of its simplicity and efficient gene
targeting.
There were many experiments testing methods developed to prevent the barriers from
occurring. In one experiment, they achieved success in preventing zoonoses because of early
weening (Egerer et al. 2018). The research focused on preventing the pigs of the porcine
cytomegalovirus (PCMV). With this virus, piglets normally get infected in the perinatal period
(Egerer et al. 2018). Twenty-four hours after birth, piglets were early-weened and isolated
(Egerer et al. 2018). Throughout fourteen months of observation, the entire herd was PCMVnegative (Egerer et al. 2018). This could be an early prevention technique to herd piglets that will
be used for organ transplantation in the future. Another technique used was CRISPR/Cas9 to
inactivate the porcine endogenous retrovirus (Niu et al. 2017). CRISPR/Cas9 was used to
inactivate the PERVs in the porcine primary cell line. This could allow for gene modifications to
inactivate the retrovirus in the pigs. The study reached success when there was a first-born pig
with inactivated PERVs (Niu et al. 2017). This just shows two successful methods that could be
used in the future to overcome potential barriers.
Success in Xenotransplantation
In one experiment, pig hearts were genetically modified and transplanted into baboons
for six months (Langin et al. 2018). All of the pig hearts were genetically modified to have α1,3galactosyltransferase knockout and to express the human membrane cofactor protein (CD46) and
human thrombomodulin (Langin et al. 2018). The experiment consisted of four different groups
that took place subsequently. After each group experiment, the researchers would make
additional changes to further prevent organ rejection. This experiment showed xenografted hearts
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that had consistent supporting function for up to 195 days which is the longest any animal had
survived with dependence on an organ from a different species at the time of the experiment
(Langin et al. 2018). This experiment showed the possibility of successful xenotransplantation
along with key techniques in carrying out the surgery. The first key point was to preserve the
intended porcine heart in non-ischaemic conditions (Langin et al. 2018). This was a change they
modified in group II after group I had negative outcomes. It showed to be significant as group II
had much more successful results after the modification. Another key point is to be able to
control the growth of the organ and prevent detrimental xenograft overgrowth (Langin et al.
2018). Overall, this study was able to show concrete evidence of success and key findings to help
advance the research in the future and show a glimpse of what is to come.
In another study, porcine islets were transplanted to fourteen patients with unstable type 1
diabetes (Matsumoto et al. 2014). Islets are groups of cells in your pancreas that contain beta
cells which produce insulin. In order to prevent organ rejection, the intended pigs for islet
transplantation were at a pathogenic free facility and had no genetic modifications (Matsumoto et
al. 2014). Different amounts of the encapsulated neonatal porcine islets were implanted into the
mice with unstable type 1 diabetes (Matsumoto et al. 2014). Results showed a decrease in bloodglucose levels and a decrease in unaware hypoglycemia events along with limited serious
adverse advance and no residual effects (Matsumoto et al. 2014). In blood glucose levels,
diabetic mice without transplantation had extremely high blood glucose levels and died after two
weeks. Mice with marginal numbers of the transplanted islets had a decrease in blood-glucose
levels, while mice with a sufficient number of transplanted islets had a larger decrease in levels
(Matsumoto et al. 2014). Even though there was a significant decrease in the blood-glucose
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levels with the porcine islets, the levels were never quite equivalent to those of mice without
diabetes. This truly shows what a wide range of diseases xenotransplantation can be used to treat.
There was research on a kidney transplant from a pig to a baboon. In order to prevent
organ rejection, the pigs were genetically modified with an immunosuppressive regime and antiinflammatory therapy (Iwase et al. 2017). Like in the previous experiment with pig hearts, the
pig kidneys had the α1,3-galactosyltransferase knockout and expressed the human membrane
cofactor protein, CD46 (Iwase et al. 2017). Specifically, the C-reactive protein was found to be
extremely important in avoiding coagulation. An increase in the C-reactive protein concentration
directly correlated with when the baboon died (Iwase et al. 2017). In the microscopic view of the
pig kidneys at biopsy after four and seven months, there were no significant abnormalities found
(Iwase et al. 2017). For over seven months, the specific genetically modified graft was able to
survive preventing nephropathy and coagulation dysfunction (Iwase et al. 2017). This showed
that with the successful prevention techniques, survival can happen. This shows that
xenotransplantation is, in fact, possible, but the hardest part is finding the correct genetic
modifications that will lead to long term survival.
Xenotransplantation can even be used as burn treatment. There are hundreds of thousands
of burn victims a year. In many cases in victims with large burns, there is often not a sufficient
amount of autologous skin available (Albritton et al. 2014). In this case, allogeneic skin is used
as a temporary coverage for the wound. There are many disadvantages to deceased-donor
allogeneic skin such as high cost, limited availability, and human pathogen transmission risk
(Albritton et al. 2014). Porcine skin grafts could be a better option as they share similarities to
human skin, have a higher availability, and are much cheaper (Albritton et al. 2014). This
experiment compared the allogeneic skin to the genetically modified pig skin. The pig skin grafts
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were genetically modified with the α1,3-galactosyltransferase knockout, called GaIT-KO
(Albritton et al. 2014). The reason this gene was genetically edited is because it is a major cell
surface target for the antibodies associated with rapid rejection of the skin grafts. By editing this
gene, it can prevent the skin rejection. There were significantly similar results with the allogeneic
skin and GaIT-KO pigskin. The results showed that the GaIT-KO pigskin did not show
accelerated rejection (Albritton et al. 2014). To further investigate, the xenogeneic and
allogeneic were applied in series where the allogeneic was applied after the xenogeneic was
applied. The results were shown to not cause accelerated rejected of the secondary allograph
(Albritton et al. 2014). The experiment was done vice-versa with the same results. Again, this
shows the importance of gene editing on that specific α1,3-galactosyltransferase knockout gene.
This study showed how xenogeneic skin grafts can be used as an early first-line treatment to treat
and manage severe burns along with being able to provide an extended period of a temporary
wound coverage for a severe burn (Albritton et al. 2014). This just shows another way in which
xenotransplantation can help in the medical field.
Another experiment examined successful and unsuccessful pig-to-baboon liver
xenotransplantation. To prevent organ rejection, pigs were genetically modified with α1,3galactosyltransferase knockout with infusions of human prothrombin concentrate complex and
an immunosuppressive regime (Shah et l. 2017). Porcine liver xenotransplantation was
performed on four baboons. On each baboon, there was an in vitro analysis, histological
examination, and a polymerase chain reaction for the porcine cytomegalovirus (pCMV) (Shah et
l. 2017). Baboon 1 was pCMV-negative and survived until day 25. Baboon 2 was pCMVnegative but was euthanized on day 5. The etiology of death was unclear as Baboon 2 had a
normal hepatic function panel (Shah et l. 2017). The hepatic function panel is a blood test that
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checks for liver disease, infection, or injury. The in vitro analysis did not find any cytotoxic
baboon antipig antibodies in the blood which shows that there is no evidence to suggest the cause
of death was due to the liver xenotransplantation (Shah et l. 2017). Baboon 3 was the only
pCMV-positive baboon and was euthanized on day 8. Unlike Baboon 2, the hepatic function
panel was worsening and there was circulating cytotoxic antibodies in the blood (Shah et l.
2017). The data for Baboon 3 shows evidence to suggest the cause of death was due to the liver
xenotransplantation. Baboon 4 was pCMV-negative and survived until day 29. Baboon 4’s
hepatic function panel was normal until its day of death when it increased and caused lower
extremity edema (Shah et l. 2017). Histological analysis indicated no presence of thrombus in the
portal vein. Also, there was no cytotoxic antibodies in the blood (Shah et l. 2017). The
experiment had an overall result of two out of the four baboons living for almost a full month
without organ rejection (Shah et l. 2017). Results also showed the significance of having a
pCMV-negative donor as it potentially could have caused faster rejection. This experiment also
showed new effective techniques to build on research to have a successful xenotransplantation.
Another experiment examined the physiologic, immunologic, and histologic properties of
genetically modified porcine lungs after perfusion with human blood (Westall et al. 2013).
Similar to aforementioned studies, genetic modifications involved the α1,3-galactosyltransferase
knockout using homologous recombination (Westall et al. 2013). After genetic modifications, the
porcine lungs were analyzed on an ex vivo rig with human blood (Westall et al. 2013). An ex
vivo perfusion is a machine that continuously pumps blood through organs to keep them warm.
An ex vivo rig allows for a thorough assessment of the organ’s function. The genetically
modified porcine lungs were compared to the wild type. The genetically modified lungs had
stable pulmonary vascular resistance (Westall et al. 2013). Compared to the wild type, the
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genetically modified lungs had better oxygenation of the perfusate and survived longer (Westall
et al. 2013). These results show the sustained function in the genetically modified porcine lung.
Even though the genetically modified lung had better physiologic function, there were still
intravascular thrombosis and coagulopathy present (Westall et al. 2013). This experiment
showed the potential benefits of methods could be developed to prevent the problems still
present.
Most of these studies took material from previous research on the negatives of
xenotransplantation and developed methods to help prevent organ rejection. A commonality was
using gene editing, mostly the CRISPR/Cas9 technique; furthermore, CRSIPR/Cas9 was used to
specifically knockout the α1,3-galactosyltransferase gene. Research indicates that there is a
critical linkage between this gene and organ rejection in xenotransplantation (Milland et al.
2005). This similarity in knockout genes shows how continued research can continue to find the
specific genes that need to be edited in order to have a successful xenotransplantation.

Most Recent Research
The most incredible part about xenotransplantation is that research is continuously
progressing. Just this year, xenotransplantation made history as the first pig heart to human
transplantation took place. David Bennett was the first brave man to risk his life on January 7,
2022 to make history for the scientific world in an absolutely groundbreaking surgery (Sade and
Mukherjee 2022)! Bennett was a 57 year old patient diagnosed with a terminal heart disease
(Sade and Mukherjee 2022). He also had an irregular heartbeat and history of not adhering to
medical advice (A man…2022). Given his history and medical conditions, Bennett was ruled
ineligible to receive a human heart transplantation (A man…2022). The Food and Drug
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Administration allowed for this experiment to take place at the University of Maryland Medical
Center under “compassionate use” because of his emergent situation (A man…2022). Basically,
Bennett faced certain death, and xenotransplantation was his last hope. Previous attempts on
xenotransplantation have failed because of rapid organ rejection. This porcine heart was
genetically modified using CRISPR/Cas9 (Sade and Mukherjee 2022). In total, there were ten
genes modified. Three genes that cause human rejection of pig organs were knocked out, and the
one gene was knocked out to stop overgrowth of the porcine heart (A man…2022). Six genes
were inserted in order to help maintain and control the immune acceptance of the new organ (A
man…2022). Interestingly, the pig donor came from a biotech company called Revivicor (A
man…2022). This company has been focusing on developing pig organs to transplant. This
shows just how prominent xenotransplantation is in the medical world today!
Bennett’s successful xenotransplantation gave him two more months of life until he died
two months after this history making story. Bennett survived significantly longer than the
previous xenotransplantation where a baby was able to live for twenty-one days after receiving a
baboon heart in 1984 (A man…2022). Throughout the past two months, Bennett seemed to have
been recovering, he even got to watch the Super Bowl. Towards the end of the two months,
Bennet declined (A man…2022). His cause of death is not yet known, but risks can include
organ rejection, immune response, inflammation, infection, and coagulation (A man…2022).
Research is currently being conducted, and answers of his cause of death will be brought to light
soon. The experiment really shows how the future is now.
Ethical Controversies
Besides the barriers that cause organ rejection, there are also ethical concerns regarding
xenotransplantation. A main reason people are against this is the main question of is it ethical to

https://digitalcommons.sacredheart.edu/acadfest/2022/all/18

14

Kruk: Future Research of Xenotransplantation to Improve Human Health

put animals through this (Cengiz and Wareham 2020). Many people think that this can be
considered animal mistreatment. What gives us the right to put them through all of this research
and be able to take their healthy organs? Another concern is the fear of objectification of animals
(Cengiz and Wareham 2020). On the other hand, others argue that we use animals for meat when
they are in our control. In this case, we are using them for the benefit of our own good just like
what we would do in xenotransplantation. Arguments even say that people think that this would
threaten human dignity (Cengiz and Wareham 2020). People believe this is disrespectful to their
body and another species should not be inside of their own being. Some people believe it is a
disruption of bodily integrity, but most people disregard this as it is aimed to improve bodily
function (Cengiz and Wareham 2020). Xenotransplantation conflict with religious views. In
many religions, certain animal are considered to be holy, and it would not be right to kill them
(Cengiz and Wareham 2020). Even religious diets conflict with xenotransplantation. The Jewish
religion follows a kosher diet where pork is prohibited. Having pig parts put in your body can go
completely against the Jewish beliefs. Some in the Catholic church views this as a violation of
the animal’s dignity, autonomy, and purpose in life. On the other hand, some Catholics view this
as morally acceptable, because humans have higher dignity than animals (Cengiz and Wareham
2020). The concept of xenotransplantation is a novel treatment, and there is no concrete answer
to if it is ethically correct. The various different views show how morally confused most people
are with xenotransplantation.
Another ethical concern is involved with gene editing. Gene editing is a key technique in
preventing organ rejection with xenotransplantation. Many people are also completely against
gene editing as it is changing the human genome (Cengiz and Wareham 2020). Without high
regulation, can gene editing get taken advantage of? Gene editing has much higher advantages
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than disadvantages, but, if it is not highly regulated, it could be extremely dangerous. Keeping
gene editing specifically for editing animal organs to prevent human organ rejection after
transplantation has little problems. If this proves to be effective, people may want to move gene
editing right to the source, humans. There are still many benefits seen in the advantages of using
gene editing, but it could potentially bring about unethical issues. For example, people could take
advantage of gene editing to try and make their offspring genetically “perfect.” Religiously, gene
editing is also a complex issue. Christians believe that humans were created in the image and
likeness of God, so would it be sinful to change the very thing that makes each and every one of
us unique to who we are? Overall, the ethical challenges are still new, and concerns can help
formulate rules and regulations for future research of xenotransplantation.
Conclusion
Yes, there are still challenges and ethical concerns associated with xenotransplantation
but look how far we have come in such little time. Just this year history was made in
xenotransplantation as a pig heart was successfully transplanted into a man who survived for two
whole months. Many of these articles talk about xenotransplantation being a future medical
treatment, but I believe the future is now. There are barriers for organ rejection, but they are
being addressed and solutions have already been developed. As said before, the science world is
exciting, and it is constantly changing. The negatives of xenotransplantation have already been
recognized which is already half of the problem. Now, all we need to do is discover the most
efficient, effective technique to prevent the negatives from occurring thus stopping organ
rejection. If we can accomplish this goal and find the ideal methods, then the future is bright for
xenotransplantation. Ethical concerns are legitimate, and they give reason to support the idea that
there needs to be extremely high regulation on this novel treatment. To me, the life-saving
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benefits vastly outweigh the negatives involved with ethical concerns. The successful research
that has been done in the past shows the endless possible organs, tissues, and cells from animals
that could be available for humans. Just in this paper, possible treatment for heart failure,
diabetes, kidney failure, burns, liver failure, and lung disease were shown, but the list of possible
treatments could go on forever. In a way, the negatives of xenotransplantation help improve the
benefits as researchers were able to address the problem and create methods to prevent the
barriers. In conclusion, I believe xenotransplantation could be a potential way to reduce organ
shortage by using animals’ organs in humans; furthermore, with increased extensive research and
high regulation, xenotransplantation could save countless lives by increasing organ availability
and transplantation rates. Everyone has experienced a death firsthand or knows of someone who
lost their life due to one of these diseases. The fact that they would still be living if there was just
organs available to them is awful and very frustrating. They were robbed of extra years of their
life due to inadequate supplies of organs, tissues, and cells. Through my research, I was able to
realize that xenotransplantation could indeed be the answer to this deathly problem of organ
shortage. The possibilities are truly endless with xenotransplantation and I truly believe it is
going to be a prominent treatment method in the health care industry in the very near future. It is
absolutely incredible that dedication to research has enabled the real possibility of successful
xenotransplantation. If we can overcome these barriers of organ rejection, xenotransplantation
will have an astronomical impact on public health. This innovative technique can save hundreds
of thousands of lives per year. Future research can include new methods to overcome the barriers
involved with organ rejection. Hopefully, when new discoveries are made, there can be more
research done on humans. Xenotransplantation could improve human life and change the
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medical world as we know it! It all starts with my fellow colleagues and I who will soon be at the
heart of the change in the medical field with our future careers.
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